Lv1
30 积分 2024-07-23 加入
Association of neoadjuvant chemotherapy dose intensity with pathological complete response and event-free survival in HER2-negative early breast cancer
2天前
已完结
Continuous low‐dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study
4个月前
已完结
Camonsertib, an ATRi, in Combination with Low-Dose Gemcitabine in Solid Tumors with DNA Damage Response (DDR) Aberrations: Preclinical and Phase 1b Results
4个月前
已完结
Evoking the Cancer-immunity cycle by targeting the tumor-specific antigens in Cancer immunotherapy
4个月前
已完结
Gemcitabine resistance in pancreatic ductal adenocarcinoma
4个月前
已完结
Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Escherichia coli Combined with Immunogenic Cell Death for Cancer Immunotherapy
5个月前
已完结
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
5个月前
已完结
Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials
7个月前
已完结
New Mechanism of Gemcitabine and Its Phosphates: DNA Polymerization Disruption via 3′–5′ Exonuclease Inhibition
7个月前
已完结
Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy
9个月前
已完结
皖公网安备34019202002308
